Results 151 to 160 of about 574,105 (363)

The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry

, 2002
Frank R. Lichtenberg, Tomas Philipson
openalex   +1 more source

Valuing Strategic Alliances in the Pharmaceutical/Biotechnology Industry [PDF]

In an era of rapid and changing technological advances, a firm's survival and growth depends on its' ability to introduce products to the market. Since a firm's growth and survival depends on its' ability to develop products and services over time ...
Jackson, Randy, McCulloch, Kathryn, Ng, Desmond W.   +2 more
core   +1 more source

The Value of Failures in Pharmaceutical R&D [PDF]

, 2012
We build a cumulative innovation model in which both success and failure provide valuable information for future research. To test this learning mechanism, we use a dataset covering outcomes of world-wide R&D projects in the pharmaceutical industry, and ...
Chiou, Jing-Yuan, Magazzini, Laura, Pammolli, Fabio, Riccaboni, Massimo   +3 more
core  

Composites of Shellac and Silver Nanowires as Flexible, Biobased, and Corrosion‐Resistant Transparent Conductive Electrodes

Advanced Functional Materials, EarlyView.
Shellac, a centuries‐old natural resin, is reimagined as a green material for flexible electronics. When combined with silver nanowires, shellac films deliver transparency, conductivity, and stability against humidity. These results position shellac as a sustainable alternative to synthetic polymers for transparent conductors in next‐generation ...
Rahaf Nafez Hussein, Tiago Carneiro Gomes, Eliza Ng, Simon Rondeau‐Gagné, Tricia Breen Carmichael   +4 more
wiley   +1 more source

Managing the Pharmaceutical Industry–Health System Interface [PDF]

, 2001
Barbara J. Zarowitz, Bruce K. Muma, Peter Coggan, Glenn M. Davis, Gregory L. Barkley   +4 more
openalex   +1 more source

Host‐Directed Biomaterials for Combatting Bloodstream Infections: From Macrocyclic Peptides to Immune‐Activating Cell Backpacks

Advanced Functional Materials, EarlyView.
Bloodstream infections (BSI) are one of the leading causes of mortality and morbidity in both civilian and military populations. This paper summarizes recent progress in novel treatment strategies to manage BSI arising from both bacterial and fungal pathogens using molecules, particles, and materials to elicit host‐directed immunity.
Thomas Thomou, Jagadish Krishnappa, Justin B. Schaal, Prasad Tongaonkar, Dat Q. Tran, Wenchao Gu, Yung‐Fu Chang, Michael E. Selsted, Shaoyi Jiang, Samir Mitragotri, Michael Super, Christopher J. Bettinger   +11 more
wiley   +1 more source

Restoring Social Legitimacy: Discursive Strategies Used By a Pharmaceutical Industry Leader

, 2009
Marc Hasbani, Gaétan Breton
openalex   +1 more source

Asymmetric Exchange Rate Exposure and Industry Characteristics : Evidence from Japanese Data [PDF]

This paper investigates the asymmetric effects of exchange rate exposure on Japanese stock returns at the industry level.Using the asymmetric correlation test of Hong et al.(2007), we examine five major currencies against the yen and thirty-three ...
Hsu, Chih-Chiang, Wu, Jyun-Yi, Yau, Ruey
core  

Tailored Reconstruction of Polycrystalline CuO Nanorods Promotes C─C Coupling in CO2 Electroreduction

Advanced Functional Materials, EarlyView.
Controlling the polycrystallinity of CuO nanorods enables directional reconstruction into rod‐like structures that stabilize Cu(OH)2 and increase Cu+ ratios, while modulating interfacial water dynamics to enhance C─C coupling and boost C2+ product formation in CO2 electroreduction.
Hyeon‐Seok Bang, Young‐Jin Ko, Hyo Sang Jeon, Eugene Huh, Eung Dab Kim, Min Gwan Ha, Chulwan Lim, Jiho Jeon, Seohyeon Ka, Dogyeong Kim, Xiaojie Zhang, Yeongjin Kim, Kyeongsu Kim, Woong Hee Lee, Jae‐Young Choi, Hyung‐Suk Oh   +15 more
wiley   +1 more source

Pharmaceutical industry and high-priced journals

, 2004
Peter Suber
openalex   +1 more source